Recombinant CTLA-4 (Ipilimumab Biosimilar) antibody

Catalog No. ABIN6964435

This anti-CTLA-4 (Ipilimumab Biosimilar) antibody is a Human Monoclonal antibody detecting CTLA-4 (Ipilimumab Biosimilar) in FACS and ELISA. Suitable for Human.

Quick Overview for Recombinant CTLA-4 (Ipilimumab Biosimilar) antibody (ABIN6964435)

Target: CTLA-4 (Ipilimumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CTLA-4 (Ipilimumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), ELISA

Grade: Research Grade

Product Details anti-CTLA-4 (Ipilimumab Biosimilar) Antibody

Purpose: Anti-CTLA4 (ipilimumab biosimilar) mAb

Characteristics: BMS-734016, MDX-010, MDX-CTLA-4

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for CTLA-4 (Ipilimumab Biosimilar)

Target: CTLA-4 (Ipilimumab Biosimilar)

Alternative Name: CTLA4 (Ipilimumab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: CTLA4, CD152

UniProt: P16410